HCV in the Hemodialysis Population: treat now or later?
University of Miami School of Medicine, Department of Medicine, Division of Digestive and Liver Diseases, 1120 NW 14th Street, Miami, Florida, 33136.
Department of Nephrology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, B-1200, Brussels, Belgium.
Université de Paris, Département d'Hépatologie, Hôpital Cochin, APHP; INSERM U1223, Institut Pasteur, Paris, France.
- Published Article
Journal of Viral Hepatitis
Wiley (Blackwell Publishing)
- Publication Date
Oct 24, 2019
Hepatitis C virus (HCV) infection remains commoner in patients with chronic kidney disease (CKD) than the population at large1 . In the hemodialysis (HD) population HCV infection in part reflects acquisition of infection within dialysis units where its transmission can be effectively prevented by meticulous attention to body fluid precautions 2 . A series of studies have confirmed that HCV transmission on HD reflects lack of adherence to these precautions 3 . In contrast to the prevention of hepatitis B transmission in this setting, dedicated dialysis machines for HCV infected patients are not recommended4 . The likelihood of HCV acquisition while on HD is increased in units with a higher background prevalence of HCV infection so an infected HD patient also places others at risk. © 2019 John Wiley & Sons Ltd.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 11/01/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31652366